Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.
D017951:Antigen Presentation; D015703:Antigens, CD / Q000378:metabolism; D051940:B7-2 Antigen; D001886:Bordetella pertussis / Q000472:pathogenicity*; D002462:Cell Membrane / Q000276:immunology; D006684:HLA-DR Antigens / Q000096:biosynthesis / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D016753:Interleukin-10 / Q000096:biosynthesis / Q000494:pharmacology; D008562:Membrane Glycoproteins / Q000378:metabolism; D009000:Monocytes / Q000187:drug effects / Q000276:immunology* / Q000382:microbiology*; D037342:Pertussis Toxin / Q000633:toxicity; D011994:Recombinant Proteins / Q000494:pharmacology
D015703:Antigens, CD; D051940:B7-2 Antigen; C497964:CD86 protein, human; D006684:HLA-DR Antigens; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D016753:Interleukin-10; D007371:Interferon-gamma; D037342:Pertussis Toxin